258 related articles for article (PubMed ID: 29244146)
21. The NSD1 and EZH2 overgrowth genes, similarities and differences.
Tatton-Brown K; Rahman N
Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):86-91. PubMed ID: 23592277
[TBL] [Abstract][Full Text] [Related]
22. Histone modification defects in developmental disorders and cancer.
Cross NC
Oncotarget; 2012 Jan; 3(1):3-4. PubMed ID: 22287508
[TBL] [Abstract][Full Text] [Related]
23. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.
Douglas J; Hanks S; Temple IK; Davies S; Murray A; Upadhyaya M; Tomkins S; Hughes HE; Cole TR; Rahman N
Am J Hum Genet; 2003 Jan; 72(1):132-43. PubMed ID: 12464997
[TBL] [Abstract][Full Text] [Related]
24. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.
Yap DB; Chu J; Berg T; Schapira M; Cheng SW; Moradian A; Morin RD; Mungall AJ; Meissner B; Boyle M; Marquez VE; Marra MA; Gascoyne RD; Humphries RK; Arrowsmith CH; Morin GB; Aparicio SA
Blood; 2011 Feb; 117(8):2451-9. PubMed ID: 21190999
[TBL] [Abstract][Full Text] [Related]
25. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
[TBL] [Abstract][Full Text] [Related]
26. Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome.
Shirahata-Adachi M; Iriyama C; Tomita A; Suzuki Y; Shimada K; Kiyoi H
Leuk Res; 2017 Dec; 63():90-97. PubMed ID: 29127861
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation.
Song X; Zhang L; Gao T; Ye T; Zhu Y; Lei Q; Feng Q; He B; Deng H; Yu L
Biomed Pharmacother; 2016 Jul; 81():288-294. PubMed ID: 27261606
[TBL] [Abstract][Full Text] [Related]
28. High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer.
Diets IJ; Waanders E; Ligtenberg MJ; van Bladel DAG; Kamping EJ; Hoogerbrugge PM; Hopman S; Olderode-Berends MJ; Gerkes EH; Koolen DA; Marcelis C; Santen GW; van Belzen MJ; Mordaunt D; McGregor L; Thompson E; Kattamis A; Pastorczak A; Mlynarski W; Ilencikova D; van Silfhout AV; Gardeitchik T; de Bont ES; Loeffen J; Wagner A; Mensenkamp AR; Kuiper RP; Hoogerbrugge N; Jongmans MC
Clin Cancer Res; 2018 Apr; 24(7):1594-1603. PubMed ID: 29351919
[No Abstract] [Full Text] [Related]
29. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
Tatton-Brown K; Loveday C; Yost S; Clarke M; Ramsay E; Zachariou A; Elliott A; Wylie H; Ardissone A; Rittinger O; Stewart F; Temple IK; Cole T; ; Mahamdallie S; Seal S; Ruark E; Rahman N
Am J Hum Genet; 2017 May; 100(5):725-736. PubMed ID: 28475857
[TBL] [Abstract][Full Text] [Related]
30. Histone code, human growth and cancer.
Crea F
Oncotarget; 2012 Jan; 3(1):1-2. PubMed ID: 22287500
[TBL] [Abstract][Full Text] [Related]
31. Further delineation of Malan syndrome.
Priolo M; Schanze D; Tatton-Brown K; Mulder PA; Tenorio J; Kooblall K; Acero IH; Alkuraya FS; Arias P; Bernardini L; Bijlsma EK; Cole T; Coubes C; Dapia I; Davies S; Di Donato N; Elcioglu NH; Fahrner JA; Foster A; González NG; Huber I; Iascone M; Kaiser AS; Kamath A; Liebelt J; Lynch SA; Maas SM; Mammì C; Mathijssen IB; McKee S; Menke LA; Mirzaa GM; Montgomery T; Neubauer D; Neumann TE; Pintomalli L; Pisanti MA; Plomp AS; Price S; Salter C; Santos-Simarro F; Sarda P; Segovia M; Shaw-Smith C; Smithson S; Suri M; Valdez RM; Van Haeringen A; Van Hagen JM; Zollino M; Lapunzina P; Thakker RV; Zenker M; Hennekam RC
Hum Mutat; 2018 Sep; 39(9):1226-1237. PubMed ID: 29897170
[TBL] [Abstract][Full Text] [Related]
32. Novel mouse model of Weaver syndrome displays overgrowth and excess osteogenesis reversible with KDM6A/6B inhibition.
Gao CW; Lin W; Riddle RC; Kushwaha P; Boukas L; Björnsson HT; Hansen KD; Fahrner JA
bioRxiv; 2023 Jun; ():. PubMed ID: 37425751
[TBL] [Abstract][Full Text] [Related]
33. EZH2 alterations in follicular lymphoma: biological and clinical correlations.
Huet S; Xerri L; Tesson B; Mareschal S; Taix S; Mescam-Mancini L; Sohier E; Carrère M; Lazarovici J; Casasnovas O; Tonon L; Boyault S; Hayette S; Haioun C; Fabiani B; Viari A; Jardin F; Salles G
Blood Cancer J; 2017 Apr; 7(4):e555. PubMed ID: 28430172
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells.
Ichikawa T; Okuno Y; Sato Y; Goshima F; Yoshiyama H; Kanda T; Kimura H; Murata T
mSphere; 2018 Nov; 3(6):. PubMed ID: 30487153
[TBL] [Abstract][Full Text] [Related]
35. EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy.
Lui JC; Garrison P; Nguyen Q; Ad M; Keembiyehetty C; Chen W; Jee YH; Landman E; Nilsson O; Barnes KM; Baron J
Nat Commun; 2016 Nov; 7():13685. PubMed ID: 27897169
[TBL] [Abstract][Full Text] [Related]
36. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis.
Wang L; Jin Q; Lee JE; Su IH; Ge K
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7317-22. PubMed ID: 20368440
[TBL] [Abstract][Full Text] [Related]
37. Loss of maternal EED results in postnatal overgrowth.
Prokopuk L; Stringer JM; White CR; Vossen RHAM; White SJ; Cohen ASA; Gibson WT; Western PS
Clin Epigenetics; 2018 Jul; 10(1):95. PubMed ID: 30005706
[TBL] [Abstract][Full Text] [Related]
38. Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.
Chase A; Score J; Lin F; Bryant C; Waghorn K; Yapp S; Carreno-Tarragona G; Aranaz P; Villasante A; Ernst T; Cross NCP
Leukemia; 2020 Dec; 34(12):3206-3214. PubMed ID: 32322039
[TBL] [Abstract][Full Text] [Related]
39. Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase.
Jani KS; Jain SU; Ge EJ; Diehl KL; Lundgren SM; Müller MM; Lewis PW; Muir TW
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8295-8300. PubMed ID: 30967505
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]